InsidersTradesSigma
Discover the full record of transactions filed by Brenner Erin K., Directeur du Développement Produit. Director active across 1 company, notably Pear Therapeutics, Inc.. Cumulatively, 1 disclosures have been published. Activity tracked since 25 May 2022. The latest transaction was disclosed on 25 May 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration
Erin K. Brenner is the Chief Product Development Officer at Pear Therapeutics, Inc. In this role, she is responsible for leading the company's product development initiatives. With a strong background in digital health, she plays a key role in innovation and creating therapeutic solutions. Her leadership is essential for achieving Pear Therapeutics' objectives.